Cognitive Behavioral Play Therapy for Children with Epilepsy
The Effects of Cognitive Behavioral Play Intervention on the Quality of Life of Children With Childhood-onset Epileptic Syndromes."
This study is testing if Cognitive Behavioral Play Therapy can help improve the quality of life for children aged 6 to 10 with epilepsy compared to regular free play.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 52 (estimated) |
| Ages | 6 Years to 10 Years |
| Sex | All |
| Sponsor | IRCCS National Neurological Institute "C. Mondino" Foundation Academic / other |
| Locations | 1 site (Pavia) |
| Trial ID | NCT06813612 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of Cognitive Behavioral Play Therapy (CBPT) in improving the quality of life for children aged 6 to 10 years diagnosed with various types of epilepsy. Participants will be randomly assigned to either the CBPT intervention group or a control group engaging in free play. The study will assess behaviors, coping strategies, positive thinking, problem-solving skills, and overall quality of life before and after the intervention. The goal is to determine if CBPT offers greater benefits compared to free play in a hospital setting.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 6 to 10 years diagnosed with specific types of epilepsy.
Not a fit: Children with epilepsy who also have cognitive disabilities or significant sensory impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the emotional and psychological well-being of children with epilepsy.
How similar studies have performed: Previous studies have shown promise for play-based interventions in pediatric populations, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
For the purposes of the study, children aged between 6 and 10 years, of both sexes, will be recruited. \- inclusion criteria Children diagnosed with the following types of epilepsy will be included: childhood self-limiting focal epilepsy (SeLFE); childhood absence epilepsy (CAE); self-limiting centrotemporal paroxysmal epilepsy (SeLECTS); self-limiting epilepsy with autonomic seizures (SeLEAS); childhood occipital epilepsy (COVE); photosensitive occipital lobe epilepsy (POLE). Exclusion criteria: * Children with epilepsy in comorbidity with cognitive disabilities (the relevant cognitive disabilities must be specified with IQ scores) * reduced visual or expressive hearing acuity (visually impaired or deaf) will be excluded.
Where this trial is running
Pavia
- Child Neuropsichiatry — Pavia, Italy (Recruiting)
Study contacts
- Principal investigator: martina paola p zanaboni, psy — IRCCS Mondino Foundation
- Study coordinator: Valentina De Giorgis, MD PhD
- Email: valentina.degiorgis@mondino.it
- Phone: 0382380289
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.